05/06/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/6/2020. This web page for healthcare professionals, updated on May 6, 2020, provides answers to frequently asked questions about COVID-19. Topics are COVID-19 Risk; Transmission; Testing, Diagnosis, and Notification; Treatment and Management; Obstetrical Care; Drugs and Investigational Therapies; Patients with Asthma; Patients with Liver Disease; and Waste Management. (Text)
05/06/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/6/2020. This web page outlines reporting requirements for laboratories for collecting and sending COVID-19/SARS-CoV-2 laboratory testing data. It also details how to report using standard terminology. (Text)
05/05/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/5/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the FTD SARS-CoV-2 test, which received an Emergency Use Authorization from the Food and Drug Administration on May 5, 2020. The FTD SARS-CoV-2 test is authorized for use on respiratory specimens collected from individuals who are suspected of coronavirus disease 2019 (COVID-19) by their healthcare provider. (PDF)
05/05/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/5/2020. This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the PhysiolGuard ECG-QT Analysis System when used in the hospital setting for remote monitoring and detection of changes in the QT interval of an electrocardiogram (ECG) in general care (i.e., not in the intensive care unit) patients who are 18 years of age or older and are undergoing treatment for COVID-19 drugs that can prolong QT intervals and may cause life threatening arrhythmias (e.g., hydroxychloroquine or chloroquine, especially when used in combination with azithromycin). (PDF)
05/05/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 5/5/2020. The aim of this 15-page document is to function as a “first port of call” for national health policymakers to support their efforts to integrate and enhance equity, gender, ethnicity, and human rights considerations and approaches into measures responding to COVID-19. It also provides links to sources of related information and guidelines. (PDF)
05/04/2020 12:00 AM EDT
Source: Alliance for Child Protection in Humanitarian Action. Published: 5/4/2020. This seven-page report examines issues that children may face as countries implement lockdowns and stay-at-home orders to curb the spread of COVID-19. Protective prevention and response strategies are then outlined with the goal of strengthening the protection of children in all types of homes. The report is published with End Violence Against Children, UNICEF, and the World Health Organization. (PDF)
05/04/2020 12:00 AM EDT
Source: National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention] (CDC NIOSH). Published: 5/4/2020. This mobile app can help healthcare and non-healthcare systems track their personal protective equipment (PPE) inventory. Facilities can use the app to calculate their average PPE consumption rate or “burn rate.” The app estimates how many days a PPE supply will last given current inventory levels and PPE burn rate. (Video or Multimedia)
05/01/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 5/1/2020. This one-hour webinar discusses the clinical importance and indications of proning, and describes the process of proning for COVID-19 cases, focusing on strategies employed and lessons learned. (Video or Multimedia)
05/01/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 5/2020. This course for healthcare workers and teams in a biocontainment unit environment provides information on many aspects of informed consent and focuses on the unique challenges with special pathogen research. This includes the process of informed consent, general requirements, telephone consent, child assent, consent of vulnerable populations, and the documentation of that process. (Video or Multimedia)
05/01/2020 12:00 AM EDT
Source: United Nations Office for the Coordination of Humanitarian Affairs, Inter-Agency Standing Committee (IASC). Published: 5/2020. This 29-page guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined need to be adjusted to the scale of transmission, context, and resources, in order to achieve the objective of managing COVID-19, namely to reduce transmission and facilitate the detection and management of infected and exposed individuals within the population. (PDF)
05/01/2020 12:00 AM EDT
Source: VashonBePrepared. Published: 5/2020. This web page describes a testing strategy that allowed a rural community to launch a successful testing site in less than three weeks using local resources, a volunteer workforce, and without resources from the county’s public health system that was already stretched thin. Following this blueprint, rural and tribal communities could stand up similar testing in one week using volunteer or professional medical and non-medical staff. Documents and printed materials are included on this page. (Text)
05/01/2020 12:00 AM EDT
Source: International Federation of Red Cross and Red Crescent Societies (IFRC). Published: 5/2020. This basic training in psychological first aid for COVID-19 outbreak response package was developed in response to the urgent need for training on how to support people in distress because of the COVID-19 outbreak. It includes interactive online training using the accompanying PowerPoints, videos, and participants' worksheet, or the training can be recorded for participants to follow when it fits their schedule. (Video or Multimedia)
04/30/2020 12:00 AM EDT
Source: Center for Infectious Disease Research and Policy [University of Minnesota] (CIDRAP). Published: 4/30/2020. This two-part report discusses how we can potentially learn from past influenza pandemics as we attempt to determine a vision for the future of the COVID-19 pandemic. Identifying key similarities and differences in the epidemiology of COVID-19 and pandemic influenza can help envisioning several possible scenarios for the course of the COVID-19 pandemic. Part 2 highlights real-world examples of effective and poor COVID-19 messaging and includes recommendations. (PDF)
04/29/2020 12:00 AM EDT
Source: United Nations (UN). Published: 4/29/2020. This 11-page guidance aims to bring awareness of the COVID-19 pandemic’s impact on persons with disabilities and their rights; draw attention to some promising practices already being undertaken around the world; identify key actions for states and other stakeholders; and provide resources for further learning about ensuring rights-based COVID-19 responses inclusive of persons with disabilities. (PDF)
04/27/2020 12:00 AM EDT
Source: Paediatric Intensive Care Society (PICS). Published: 4/27/2020. This two-page document provides information about an alert in the United Kingdom related to toxic shock and Kawasaki-like symptoms appearing in some pediatric COVID-19 patients. Public health officials in New York and elsewhere are distributing notices to local health systems to inform pediatricians of the potential connection between the condition and SARS-CoV-2. (PDF)
04/01/2020 12:00 AM EDT
Source: Centre for Research on the Epidemiology of Disasters, a WHO Collaborating Centre (CRED). Published: 4/2020. This two-page report, co-published with the U.S. Agency for International Development, provides information and data about disasters in 2019, when at least 396 natural disasters were reported, killing 11,755 people, affecting 95 million others, and costing nearly $130 billion. Topics include human impact and wildfires, and a table shows number of disaster events by continent. (PDF)
03/01/2020 12:00 AM EST
Source: National Academies of Sciences, Engineering, and Medicine. Published: 3/2020. This web page provides information about the National Academies of Science, Engineering, and Medicine Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, and links to the committee's COVID-19 Rapid Expert Consultations. The committee anticipates beginning to focus on intermediate-term questions, where the answers have a time constant measured in weeks to months rather than hours to days. (Text)
No hay comentarios:
Publicar un comentario